SCHEMBL24853587

SCHEMBL24853587

C/C=C(\C)c1nc2ccccc2c2occc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.36
▸ MAPT P10636 4/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ LMNA P02545 3/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ KCNA3 P22001 1/20 0.33
▸ GPR3 P46089 1/20 0.33
▸ HTT P42858 2/20 0.32
▸ HRH4 Q9H3N8 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ PDE4A P27815 1/20 0.32
▸ PDE4B Q07343 1/20 0.32
▸ PDE4C Q08493 1/20 0.32
▸ PDE4D Q08499 1/20 0.32
▸ PDE5A O76074 1/20 0.32
▸ REN P00797 1/20 0.32
▸ ELANE P08246 2/20 0.32
▸ TP53 P04637 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24854100 0.88 GPR3 (0.36) ALDH1A1MAPTKDM4ESMN1; SMN2HPGD
SCHEMBL24853807 0.75 ALDH1A1 (0.42) ALDH1A1MAPTKDM4ELMNASMN1; SMN2
SCHEMBL29634253 0.73 KMT2A (0.47) ALDH1A1MAPTKDM4ELMNASMN1; SMN2
SCHEMBL7262166 0.70 MAOA (0.45) ALDH1A1KDM4ESMN1; SMN2HPGDKCNA3
SCHEMBL22431673 0.70 CSNK2A1 (0.38) ALDH1A1MAPTKDM4ESMN1; SMN2HPGD
SCHEMBL24853596 0.70 ALDH1A1 (0.36) ALDH1A1MAPTKDM4ELMNASMN1; SMN2
SCHEMBL24853579 0.69 TP53 (0.34) MAPTLMNASMN1; SMN2HPGDELANE
SCHEMBL7263567 0.67 PDE5A (0.56) ALDH1A1KDM4ELMNASMN1; SMN2HPGD
SCHEMBL24853790 0.67 GPR3 (0.36) ALDH1A1MAPTKDM4ESMN1; SMN2HPGD
SCHEMBL24854586 0.66 NUDT1 (0.42) ALDH1A1MAPTKDM4ELMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002427-A1 ORGANOMETALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-01-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002427-A1 ORGANOMETALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME NONO, BMI1, LIG1 ALDH1A1 745/4885MAPT 1638/4885KDM4E 532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback